2026-09-19T00:28:11Z https://api.figshare.com/v2/oai

oai:figshare.com:article/31341331 2026-02-16T19:26:11Z portal_693 item_type_8 month_year_02_2026

Organizational Readiness for Transformational Partnerships in Biopharmaceutical Companies Kelly Olsson (22799519) Organizational readiness for change Adaptive Leadership Pharmaceutical and health care Primary Prevention of the Disease cardiometabolic disease prevented Transformational - transactional leadership Partnerships in healthcare cross sector collaboration Public health partnerships <p dir="ltr">This research explores biopharmaceutical companies' organizational readiness for transformational partnerships and more specifically, for the prevention of CMDs (phenomenon of interest). The researcher posited a relationship between organizational, leadership, and readiness factors and organizational readiness to engage in transformational partnerships within biopharmaceutical companies. A sequential, qualitative research design was utilized to maximize the assessment of the current state of organizational readiness for subunits of prevention and partnership in context. Results from a document analysis and semi-structured interviews, the researcher concluded that there are challenges for BC organizational-level readiness for effective and impactful achievement of SDG 3 via transformational partnerships that will have a significant impact on population health; however, a great deal of thought, effort, and motivation is present. These insights highlight the practice- and leadership-oriented elements that support more transformational, systems-level change.</p> 2026-02-17T00:00:00Z Text Thesis 10.25417/uic.31341331.v1 https://figshare.com/articles/thesis/Organizational_Readiness_for_Transformational_Partnerships_in_Biopharmaceutical_Companies/31341331 In Copyright